Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Apr;75(4):1388–1390. doi: 10.1172/JCI111840

Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia.

W H Raskind, R Jacobson, S Murphy, J W Adamson, P J Fialkow
PMCID: PMC425469  PMID: 3921571

Abstract

Previous studies with the X-chromosome-linked glucose-6-phosphate dehydrogenase (G6PD) as a marker of cellular mosaicism demonstrated that polycythemia vera (PV) and essential thrombocythemia (ET) are clonal disorders of hematopoietic stem cells that can differentiate to erythrocytes, granulocytes, and platelets. To determine if the involved stem cells could also differentiate along the B-lymphoid pathway, we studied one woman with PV and one woman with ET. Of 117 Epstein-Barr virus-transformed B-lymphoblastoid lines expressing a single G6PD derived from the patient with PV, 108 expressed G6PD type A, the type characteristic of the abnormal clone. The ratio of 108:9 was significantly different from the one to one ratio predicted for this patient, which suggested that at least some circulating progenitors for B-lymphoid cell lines differentiate from the stem cell involved by the disease. Results obtained from the patient with ET were similar--104 of the 109 lymphoblastoid lines monotypic for G6PD expression displayed the enzyme type found in the abnormal clone of marrow cells. Therefore, in these patients, PV and ET, like chronic myelogenous leukemia, involve a stem cell pluripotent for the lymphoid as well as the myeloid series.

Full text

PDF
1388

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson J. W., Fialkow P. J., Murphy S., Prchal J. F., Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med. 1976 Oct 21;295(17):913–916. doi: 10.1056/NEJM197610212951702. [DOI] [PubMed] [Google Scholar]
  2. Bentwich Z., Douglas S. D., Skutelsky E., Kunkel H. G. Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells. J Exp Med. 1973 Jun 1;137(6):1532–1537. doi: 10.1084/jem.137.6.1532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bernheim A., Berger R., Preud'homme J. L., Labaume S., Bussel A., Barot-Ciorbaru R. Philadelphia chromosome positive blood B lymphocytes in chronic myelocytic leukemia. Leuk Res. 1981;5(4-5):331–339. doi: 10.1016/0145-2126(81)90005-9. [DOI] [PubMed] [Google Scholar]
  4. Fialkow P. J. Cell lineages in hematopoietic neoplasia studied with glucose-6-phosphate dehydrogenase cell markers. J Cell Physiol Suppl. 1982;1:37–43. doi: 10.1002/jcp.1041130409. [DOI] [PubMed] [Google Scholar]
  5. Fialkow P. J., Denman A. M., Jacobson R. J., Lowenthal M. N. Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest. 1978 Oct;62(4):815–823. doi: 10.1172/JCI109193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fialkow P. J., Faguet G. B., Jacobson R. J., Vaidya K., Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood. 1981 Nov;58(5):916–919. [PubMed] [Google Scholar]
  7. Fialkow P. J., Gartler S. M., Yoshida A. Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci U S A. 1967 Oct;58(4):1468–1471. doi: 10.1073/pnas.58.4.1468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fialkow P. J., Martin P. J., Najfeld V., Penfold G. K., Jacobson R. J., Hansen J. A. Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood. 1981 Jul;58(1):158–163. [PubMed] [Google Scholar]
  9. Fialkow P. J. Primordial cell pool size and lineage relationships of five human cell types. Ann Hum Genet. 1973 Jul;37(1):39–48. doi: 10.1111/j.1469-1809.1973.tb01813.x. [DOI] [PubMed] [Google Scholar]
  10. Gaetani G. F., Ferraris A. M., Galiano S., Giuntini P., Canepa L., d'Urso M. Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in a GdB/GdMediterranean subject. Blood. 1982 Jan;59(1):76–79. [PubMed] [Google Scholar]
  11. Karande A., Fialkow P. J., Nilsson K., Povey S., Klein G., Najfeld V., Penfold G. Establishment of a lymphoid cell line from leukemic cells of a patient with chronic lymphocytic leukemia. Int J Cancer. 1980 Nov 15;26(5):551–556. doi: 10.1002/ijc.2910260505. [DOI] [PubMed] [Google Scholar]
  12. Levitt M. L., Barry W. E., Helfrich M. K., Hecht B. K., Henderson E. E. Characterization of Epstein-Barr virus-carrying cell lines established from chronic lymphocytic leukemia. Cancer Res. 1983 Mar;43(3):1195–1203. [PubMed] [Google Scholar]
  13. Martin P. J., Najfeld V., Hansen J. A., Penfold G. K., Jacobson R. J., Fialkow P. J. Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature. 1980 Sep 4;287(5777):49–50. doi: 10.1038/287049a0. [DOI] [PubMed] [Google Scholar]
  14. Najfeld V., Fialkow P. J., Karande A., Nilsson K., Klein G., Penfold G. Chromosome analyses of lymphoid cell lines derived from patients with chronic lymphocytic leukemia. Int J Cancer. 1980 Nov 15;26(5):543–549. doi: 10.1002/ijc.2910260504. [DOI] [PubMed] [Google Scholar]
  15. Raskind W. H., Tirumali N., Jacobson R., Singer J., Fialkow P. J. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood. 1984 Jun;63(6):1318–1323. [PubMed] [Google Scholar]
  16. Rickinson A. B., Finerty S., Epstein M. A. Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells. Clin Exp Immunol. 1982 Nov;50(2):347–354. [PMC free article] [PubMed] [Google Scholar]
  17. Sparkes R. S., Baluda M. C., Townsend D. E. Cellulose acetate electrophoresis of human glucose-6-phosphate dehydrogenase. J Lab Clin Med. 1969 Mar;73(3):531–534. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES